Letter: factors that may predict response to ciclosporin in ulcerative colitis - authors' reply

被引：0
|
作者：
Katsuno, T. [1 ]
Saito, K. [1 ]
Yokosuka, O. [1 ]
机构：
[1] Chiba Univ, Dept Med & Clin Oncol K1, Grad Sch Med, Chiba, Japan
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2013年 / 37卷 / 06期
关键词：
FATTY LIVER-DISEASE; APPLICABILITY; DIAGNOSIS; ACCURACY; FIBROSIS; INJURY; BIOPSY;
D O I：
10.1111/apt.12235
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：655 / 655
页数：1
相关论文
共 50 条
  • [1] Letter: factors that may predict response to ciclosporin in ulcerative colitis
    Farkas, K.
    Balint, A.
    Nagy, F.
    Szepes, Z.
    Szucs, M.
    Wittmann, T.
    Molnar, T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (06) : 654 - 654
  • [2] Letter: ciclosporin or infliximab in acute ulcerative colitis - still undecided; authors' reply
    Croft, A.
    Walsh, A.
    Doecke, J.
    Radford-Smith, G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (08) : 993 - 993
  • [3] Commentary: predicting response to ciclosporin in acute severe ulcerative colitis - authors' reply
    Katsuno, T.
    Saito, K.
    Yokosuka, O.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (11-12) : 1096 - 1097
  • [4] Letter: mucosal PCR for cytomegalovirus in refractory ulcerative colitis - authors' reply
    Chaparro, M.
    Gisbert, J. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (08) : 812 - 812
  • [5] Letter: biological drugs for inducing remission in ulcerative colitis - authors' reply
    Stidham, R. W.
    Lee, T. C. H.
    Higgins, P. D. R.
    Deshpande, A. R.
    Sussman, D. A.
    Singal, A. G.
    Elmunzer, B. J.
    Saini, S. D.
    Vijan, S.
    Waljee, A. K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) : 1244 - 1244
  • [6] Letter: which patient profile for tacrolimus in ulcerative colitis? Authors' reply
    Yamamoto, T.
    Shimoyama, T.
    Umegae, S.
    Matsumoto, K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (11) : 1243 - 1243
  • [7] Letter: dose optimising infliximab in acute severe ulcerative colitis - authors' reply
    Casteele, N. Vande
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (01) : 82 - 82
  • [8] Letter: Should ulcerative colitis be monitored more or less invasively? Authors' reply
    Lenfant, Matthias
    Verstockt, Bram
    Sabino, Joao
    Vermeire, Severine
    Ferrante, Marc
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (05) : 723 - 724
  • [9] Letter: dose optimising infliximab in acute severe ulcerative colitis - authors' reply
    Jairath, V.
    Casteele, N. V.
    Hindryckx, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (08) : 1170 - 1171
  • [10] Letter: ulcerative colitis in patients transplanted for primary sclerosing cholangitis - authors' reply
    Navaneethan, U.
    Venkatesh, P. G. K.
    Kiran, R. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (03) : 297 - 297
12345